Search Results
Jul 21, 2026, 09:00 ET A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening
track for the fourth quarter of 2026.The broader field is heating up, with Compass Pathways (NASDAQ: CMPS), GH Research (NASDAQ: GHRS), Definium Therapeutics (NASDAQ: DFTX), and Johnson & Johnson (NYSE: JNJ) all advancing or commercializing novel approaches to difficult-to-treat
More news about: USA News Group
Jul 17, 2026, 08:50 ET Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
was historically its largest shareholder, though that stake had fallen to 4.96% as of a February 2026 filing.GH Research PLC (NASDAQ: GHRS) was the sharpest mover, jumping roughly 15%, and the reason is mechanistic. GH Research develops proprietary mebufotenin therapies, mebufotenin being
More news about: USA News Group
Jun 26, 2026, 09:30 ET A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year
program like HLP003 may be received — while also illustrating the competitive intensity Helus faces in the space.GH Research (NASDAQ: GHRS), a Dublin-based clinical-stage company developing its own novel-mechanism candidate for treatment-resistant depression, rounds out the set as another
More news about: USA News Group
Mar 09, 2026, 10:50 ET CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions
Compass Pathways (NASDAQ: CMPS), AtaiBeckley (NASDAQ: ATAI), Definium Therapeutics (NASDAQ: DFTX), and GH Research (NASDAQ: GHRS).
More news about: USA News Group
Feb 27, 2026, 11:44 ET Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments
there: Helus Pharma (NASDAQ: HELP), AtaiBeckley (NASDAQ: ATAI), Definium Therapeutics (NASDAQ: DFTX), GH Research (NASDAQ: GHRS), and LB Pharmaceuticals (NASDAQ: LBRX).
More news about: Equity Insider
Oct 28, 2025, 08:42 ET Georgia House Rabbit Society Calls on Petland to End Rabbit Sales
Gurley, Shelter Manager of GHRS. "Young rabbits are often sent home with families who don't yet understand their specialized needs. Weeks later, many of those same rabbits arrive at our rescue underweight, frightened, and in need of veterinary care." GHRS, a Kennesaw-based nonprofit
More news about: Rabbit.org Foundation